TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07223333: A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Sponsor: AdipoPharma LLC · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 56 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$1,467,440

Rescue Site Savings

+$970,768

Unlock Full NCT07223333 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07223333 Rescue Dossier →